-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
December 09, 2009 - are looking for other options beyond pharmacologic therapy. … How do these non-pharmacologic treatments compare with pharmacological
treatments in efficacy or effectiveness … How do the efficacy, effectiveness, or harms of treatment with non-pharmacologic treatments
for treatment-resistant … or racial groups, and sex);
• Patients with medical comorbidities (e.g., seizure history, stroke, diabetes … New treatments without a current
evidence that require further research, such as Magnetic Seizure Therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
October 01, 2010 - Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … outcomes, including frequency of required intravenous
antibiotic treatments, frequency of hospitalization … duration, baseline nutritional status,
and concurrent medical therapies? … (gender, age, ethnicity, nutritional status);
comorbidities; and use of concurrent standard medical
therapies … The usage of concurrent medical therapies in patients
enrolled in trials evaluating rhGH therapy was
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
July 10, 2018 - veterans.3,4 PTSD
is also associated with cardiovascular disease, arthritis, asthma, chronic pain, diabetes … (CPT), Eye Movement Desensitization and Reprocessing (EMDR), specific cognitive behavioral
therapies … Processing Therapy. … traumatic stress disorder" or PTSD).ti,ab.
3. th.fs.
4. exp Psychotherapy/
5. exp Complementary Therapies … /
6. exp Convulsive Therapy/
7.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
July 10, 2018 - veterans.3,4 PTSD
is also associated with cardiovascular disease, arthritis, asthma, chronic pain, diabetes … (CPT), Eye Movement Desensitization and Reprocessing (EMDR), specific cognitive behavioral
therapies … Processing Therapy. … traumatic stress disorder" or PTSD).ti,ab.
3. th.fs.
4. exp Psychotherapy/
5. exp Complementary Therapies … /
6. exp Convulsive Therapy/
7.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
May 01, 2016 - separate from obesity and may be independently related to
chronic pain, other psychiatric disorders, and diabetes … Psychological and behavioral therapy
interventions include cognitive behavioral therapy (CBT),
interpersonal … BWL
therapy
2 170
BWL decreased BMI more than CBT at the end of treatment. ���
CBT decreased binge-eating … was likely managed
by a psychiatrist and psychological and behavioral
therapy treatments were likely … Behavioral weight-loss therapy
Treatment that incorporates various behavioral strategies, such
as caloric
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - analysis Death within the first 3 months after SARS-CoV-2 infection, active chemotherapy, previous therapy … were included in this analysis Death within the first 3 months after SARS-CoV-2 infection, previous therapy … radiological suspicion of infection, cancer patients at high risk for infection and eligible for active therapy … Severe Obesity: 5 (3.1)*
Immunosuppresssed (e.g., HIV, autoimmune disease): 2 (1.3)*
Immune-weakening therapy … sample was taken)
Median (IQR) days from symptom onset to testing: 6 (3-9) Asymptomatic: 34* (19.2)* Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - All three KQs consider subgroups by age,
sex, weight, body mass index, diabetes, heart failure,
previous … , anticoagulant therapy, and combined therapies
were published. … currently in use (such as specific components
of treatments considered to be supportive therapy), and … For example, in a study
comparing antithrombotic therapies, a proportion of
patients in each treatment … Regarding the invasive treatment strategy in UA/NSTEMI
patients, this review found that several therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
December 11, 2012 - The cornerstone of short- and long-term treatment in all cases is medical
therapy with antiplatelet … )
○ Adverse effects of treatments
1. … Postdischarge treatment
KQ 1
KQs 1, 2, 3
Individual characteristics
• Age
• Sex
• Diabetes
• Weight … , anticoagulant
therapy, and combined therapies were published. … currently in use (such as
specific components of treatments considered to be “optimal medical therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
January 01, 2024 - Prospective randomized evaluation of idiopathic hyperoxaluria treatments. … Prospective randomized evaluation of idiopathic hyperoxaluria treatments. … ED visit only:
Selective therapy: 7%
Empiric therapy: 7%
Hospitalization only:
Selective therapy: 2% … Empiric therapy: 2%
Surgery only:
Selective therapy: 8%
Empiric therapy: 7% NR NR NR NR NR NR NR NR … Prospective randomized evaluation of idiopathic hyperoxaluria treatments.
-
effectivehealthcare.ahrq.gov/products/transparency-neuropathy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
October 08, 2014 - Alternatively, CNI
use may be withdrawn or avoided entirely in favor of other immunosuppressant therapies … Therapeutic monitoring (KQ1a, KQ1b, KQ2). … monitoring of CNIs and CNI treatment strategies. … of patients receiving each specific ancillary treatment? … Were patients blinded to the treatment they received?
14.
-
effectivehealthcare.ahrq.gov/products/sleep-apnea/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
October 01, 2007 - of
individual patients or weighing the implications of particular poli-
cies affecting medical therapies … clinical and policy
decisions at different levels of the health care system, as
illustrated in Table 1 for treatments … randomization provides against sources of bias and
confounding that often affect observational studies, where
treatments … Decisions Relevant to Medical Therapies
(Example: Therapy for Osteoporosis)
Drug approval—Is slow release … is equally
effective in patients with diabetes and nondiabetics on a relative
scale (roughly 25% reduction
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
June 01, 2012 - clinician deciding on which diagnostic or prognostic tests to use for his or her frail, older patient with diabetes … Assessing Applicability (4 of 4)
The third challenge arises because medical tests, even more so than treatments … The underlying prevalence of undiagnosed type 2 diabetes in pregnancy is increased. … in light of new therapeutics. … Important Contextual Factors (9 of 10)
The sixth and final contextual factor to consider is changes in therapeutics
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
June 01, 2012 - clinician deciding on which diagnostic or prognostic tests to use for his or her frail, older patient with diabetes … Assessing Applicability (4 of 4)
The third challenge arises because medical tests, even more so than treatments … The underlying prevalence of undiagnosed type 2 diabetes in pregnancy is increased. … in light of new therapeutics. … Important Contextual Factors (9 of 10)
The sixth and final contextual factor to consider is changes in therapeutics
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
February 01, 2012 - adolescents (10–17 years)
Bipolar disorder (depression)
Adults Bipolar disorder (maintenance)
Adjunctive therapy … with other therapies, there is a paucity of data
regarding the efficacy and effectiveness of 1st or … Large prospective cohort
designs that follow youth with a range of mental health disorders and treatments … adolescents (10–17 years)
Bipolar disorder (depression)
Adults Bipolar disorder (maintenance)
Adjunctive therapy … An RCT has to be large,
because the question
compares active treatments,
and the effect size may be
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_disposition-comments.pdf
January 01, 2012 - Diabetes
Technol Ther 2010;12:575-579. … title above the actual wording "appendix C" it cites
"comparative effectiveness of the diagnosis and treatment … to “criteria” and added in
parenthesis “(including populations, settings,
interventions, control treatment … The emphasis on
tailoring treatment to specific patient situations (avoiding
overtreatment or undertreatment … Regarding the therapeutic targets for home BP we
believe that this is still an area of uncertainty.
-
effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
January 01, 2007 - Improving Depiction of Benefits and Harms:
Analyses of Studies of Well-known Therapeutics and Review … Can Between-Physician Differences in Prescribing Patterns Be Used to
Estimate Treatment Effects? … Heterogeneity and Treatment Effect
Estimates from Risk-Adjustment and Instrumental Variable Methods … Constantine Frangakis Using Propensity
Scores Subclassification to Estimate Effects of Longitudinal Treatments … : An Example
Using a New Diabetes Medication.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/presentations-future_research.pdf
April 01, 2012 - These eight reports were:
Prioritizing Research Needs in Gestational Diabetes Mellitus (Johns Hopkins … 20
Inhaled Nitric Oxide Therapy for Premature Infants. … treatment to an
existing treatment
after treatment
failure
Initial treatment with
psychosocial … and/or
pharmacologic
treatments
or
Continuation of
existing treatment
without addition of
psychosocial … Future Research Needs for the Management of
Gestational Diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-outcomes_disposition-comments.pdf
January 15, 2015 - measures
chosen and how are they anchored in values for general
medical populations (e.g. if rates of diabetes … both recognize the need for adjunctive therapy for
many patients with SMI. … treatment. … Report Section Comment Response
KI Reviewer #4 Findings With non-psychiatric disorders such as diabetes … Druss BG, Zhao L, Cummings JR, et al.: Mental
comorbidity and quality of diabetes care under Medicaid